Efficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-08-14 / PLoS ONE 2014;9(8):e105266Attacking Postoperative Metastases using Perioperative Oncolytic Viruses and Viral Vaccines
/in International Publications, Newcastle Disease Virus /von 2014-08-12 / Front Oncol 2014;4:217Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice
/in Dendritic Cells, Exosome, Glioblastoma, Hypernephroma, International Publications /von 2014-08-05 / Int. J. Cancer 2015 Feb;136(4):E74-84Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer
/in Breast Cancer, Hyperthermia, International Publications /von 2014-08-01 / Int J Hyperthermia 2014 Aug;30(5):285-94The effect of stress on efficacy of dendritic cell therapy for esophageal squamous cell carcinoma.
/in Dendritic Cells, Hyperthermia, International Publications /von 2014-07-31 / J Clin Oncol 32, 2014 (suppl 3; abstr 69)Response of blood flow to hyperthermia in human prostate tumors: Opportunities for enhanced radiation effect and drug delivery.
/in Hyperthermia, International Publications, Prostate Cancer /von 2014-07-31 / J Clin Oncol 32, 2014 (suppl 4; abstr 189)A phase I, open label, dose escalation and cohort expansion study to evaluate the safety and immune response to autologous dendritic cells (DC) transduced with AdGMCA9 (DC-AdGMCAIX) in patients with mRCC.
/in Dendritic Cells, Hypernephroma, International Publications /von 2014-07-31 / J Clin Oncol 32, 2014 (suppl 4; abstr 490)Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells
/in International Publications, Newcastle Disease Virus, NSCLC /von 2014-07-30 / BMC Cancer 2014 Jul;14:551Sorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma: A phase II study
/in Hepatocellular Carcinoma, Hyperthermia, International Publications /von 2014-07-24 / Oncol Lett 2014 Oct;8(4):1783-1787
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de